Trial intelligence / Profile preview

Quadruple vs Triple Therapy for H. pylori Eradication

NCT01667575Phase 4Completed

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Aug 2012
Primary completion
May 2013
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 4 trial of bismuth subcitrate in Helicobacter pylori infection, sponsored by Shanghai Jiao Tong University School of Medicine. Started Aug 2012; status: completed.

02

Drugs

bismuth subcitrate
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT01667575.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01667575.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call